Terms: = Cervical cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246
48 results:
1. γδ T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids.
Dong J; Holthaus D; Peters C; Koster S; Ehsani M; Quevedo-Olmos A; Berger H; Zarobkiewicz M; Mangler M; Gurumurthy RK; Hedemann N; Chumduri C; Kabelitz D; Meyer TF
Front Immunol; 2023; 14():1281646. PubMed ID: 38090581
[TBL] [Abstract] [Full Text] [Related]
2. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
3. Role of MLH1 and msh2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications.
Dutta P; Pal D; Roy A; Mandal RK; Panda CK
Gene; 2023 Dec; 888():147746. PubMed ID: 37657688
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of PD-L1 expression and MMR status between primary and matched metastatic lesions in patients with cervical cancer.
Liu H; Sun L; Lian J; Wang L; Xi Y; Zhao G; Wang J; Lan X; Du H; Yan W; Bu P; Wang P; Moore A; Zhao H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11397-11410. PubMed ID: 37378674
[TBL] [Abstract] [Full Text] [Related]
5. cervical Adenocarcinoma: A Still Under-investigated Malignancy.
Pistolesi S; Fanelli GN; Giudice F; Garbini F; Naccarato AG; Cosio S; Caretto M; Gadducci A
Anticancer Res; 2023 Jan; 43(1):53-58. PubMed ID: 36585201
[TBL] [Abstract] [Full Text] [Related]
6. The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome.
Kang YJ; Caruana M; McLoughlin K; Killen J; Simms K; Taylor N; Frayling IM; Coupé VMH; Boussioutas A; Trainer AH; Ward RL; Macrae F; Canfell K
Genet Med; 2022 Sep; 24(9):1831-1846. PubMed ID: 35809086
[TBL] [Abstract] [Full Text] [Related]
7. circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating msh2 in cervical cancer.
Wu P; Qin J; Liu L; Tan W; Lei L; Zhu J
Aging (Albany NY); 2022 Jul; 14(13):5406-5416. PubMed ID: 35779530
[TBL] [Abstract] [Full Text] [Related]
8. Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic cancers.
Noh JJ; Kim MK; Choi MC; Lee JW; Park H; Jung SG; Joo WD; Song SH; Lee C
Cancer Res Treat; 2022 Oct; 54(4):1200-1208. PubMed ID: 34902958
[TBL] [Abstract] [Full Text] [Related]
9. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract] [Full Text] [Related]
10. PD-L1 expression and immune stromal features in HPV-independent cervical adenocarcinoma.
Song F; Jia M; Yu S; Cao L; Sun PL; Gao H
Histopathology; 2021 Nov; 79(5):861-871. PubMed ID: 34156708
[TBL] [Abstract] [Full Text] [Related]
11. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
[TBL] [Abstract] [Full Text] [Related]
12. Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis.
Ocadiz-Delgado R; Lizcano-Meneses S; Trejo-Vazquez JA; Conde-Perezprina JC; Garrido-Palmas F; Alvarez-Rios E; García-Villa E; Ruiz G; Illades-Aguiar B; Leyva-Vázquez MA; García-Carrancá A; Gariglio P
APMIS; 2021 Feb; 129(2):70-79. PubMed ID: 33112434
[TBL] [Abstract] [Full Text] [Related]
13. TOP2A and CENPF are synergistic master regulators activated in cervical cancer.
Yu B; Chen L; Zhang W; Li Y; Zhang Y; Gao Y; Teng X; Zou L; Wang Q; Jia H; Liu X; Zheng H; Hou P; Yu H; Sun Y; Zhang Z; Zhang P; Zhang L
BMC Med Genomics; 2020 Oct; 13(1):145. PubMed ID: 33023625
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix.
Carroll MR; Ramalingam P; Salvo G; Fujimoto J; Solis Soto LM; Phoolcharoen N; Hillman RT; Cardnell R; Byers L; Frumovitz M
Int J Gynecol Cancer; 2020 Sep; 30(9):1303-1307. PubMed ID: 32727929
[TBL] [Abstract] [Full Text] [Related]
15. HPV nonrelated endocervical adenocarcinoma in hereditary cancer syndromes.
Carnevali I; Di Lauro E; Pensotti V; Sahnane N; Leoni E; Formenti G; Ghezzi F; Sessa F; Tibiletti MG
Tumori; 2020 Dec; 106(6):NP67-NP72. PubMed ID: 32635821
[TBL] [Abstract] [Full Text] [Related]
16. Metastatic rectal cancer to papillary thyroid carcinoma: a case report and review of literature.
Luo M; Huang Y; Li Y; Zhang Y
BMC Gastroenterol; 2020 May; 20(1):136. PubMed ID: 32375670
[TBL] [Abstract] [Full Text] [Related]
17. Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing.
Garg S; Nagaria TS; Clarke B; Freedman O; Khan Z; Schwock J; Bernardini MQ; Oza AM; Han K; Smith AC; Stockley TL; Rouzbahman M
Mod Pathol; 2019 Dec; 32(12):1823-1833. PubMed ID: 31308508
[TBL] [Abstract] [Full Text] [Related]
18. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract] [Full Text] [Related]
19. Lynch Syndrome-Related Clear Cell Carcinoma of the Cervix: A Case Report.
Nakamura K; Nakayama K; Minamoto T; Ishibashi T; Ohnishi K; Yamashita H; Ono R; Sasamori H; Razia S; Hossain MM; Kamrunnahar S; Ishikawa M; Ishikawa N; Kyo S
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587389
[TBL] [Abstract] [Full Text] [Related]
20. Molecular markers of DNA damage and repair in cervical cancer patients treated with cisplatin neoadjuvant chemotherapy: an exploratory study.
Real NE; Castro GN; Darío Cuello-Carrión F; Perinetti C; Röhrich H; Cayado-Gutiérrez N; Guerrero-Gimenez ME; Ciocca DR
Cell Stress Chaperones; 2017 Nov; 22(6):811-822. PubMed ID: 28608263
[TBL] [Abstract] [Full Text] [Related]
[Next]
